Prostate Cancer ADT Raises Dementia Risk, Study Finds
Androgen deprivation therapy for prostate cancer is associated with a significant 20% increased risk of dementia and 14% increased risk of Alzheimer’s disease, a study found.
Prostate Cancer
Urine Biomarker Helps Classify Risk Level in Prostate Cancer
Urine-derived extracellular vesicle RNA provides diagnostic, prognostic information in prostate cancer
Prostate Cancer Salvage Cryotherapy May Offer Durable Tumor Control
In a study, patients who underwent salvage cryotherapy for radiorecurrent prostate cancer had cancer-specific and metastasis-free survival rates of 81% and 78%, respectively, at 12 years.
Alcohol and Prostate Cancer: How Is Intake Associated With Risk of Death and/or Metastasis?
This data analysis examined the effect of alcohol consumption on the risk of lethal prostate cancer in men at risk of the disease, and those who developed nonmetastatic prostate cancer during follow-up.
Prostate Cancer Treatment Regimens
Find detailed treatment options for prostate cancer, including clinical trials and anticancer agents such as docetaxel, prednisone, and sipuleucel-T.
Location of Body Fat Linked to Advanced, Fatal Prostate Cancer
Risk for advanced, fatal disease also increased in association with body mass index, waist circumference.
More Advanced PCa Diagnoses Followed USPSTF Screening Recommendations
Nodal and metastatic prostate cancer at diagnosis increased after 2008, when the USPSTF recommended against PSA screening for men aged 75 or older, and again when it expanded the recommendation for all men.
PET/CT Imaging for Recurrent PCa Detection More Accurate With PSMA
In a head-to-head comparative study involving PCa patients with early biochemical recurrence following radical surgery, PSMA PET/CT had significantly higher cancer detection rates than fluciclovine PET/CT.
Guidelines Updated for Radiotherapy After Prostatectomy
Updates include adjuvant radiotherapy for patients with adverse pathologic findings, hormonal therapies.
Visceral Metastases on the Rise in Metastatic Prostate Cancer
The proportion of men with metastatic prostate cancer who develop visceral metastases rose from 26% in 2009 to 40% in 2016, a study found.
Next post in Prostate Cancer
